Drugs Made In America Acquisition (DMII) Cash & Equivalents (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Cash & Equivalents of $223.0 for Q4 2025, down 98.69% year-over-year from $17035.0 in Q4 2024, and down 99.93% quarter-over-quarter from $315087.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Cash & Equivalents (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 2 years of Cash & Equivalents data on file, last reported at $223.0 in Q4 2025.
- Cash & Equivalents for Q4 2025 came in at $223.0, down 98.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $223.0 (down 98.69% YoY), and the FY2025 annual result was $223.0, down 98.69% from the prior year.
- Cash & Equivalents declined to $223.0 in Q4 2025 per DMII's latest filing, from $315087.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $315087.0 in Q3 2025 and troughed at $223.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 1.47 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 112,660.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 209,016.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 167,798.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 28,828.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 553,972.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 1.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 521,352.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | 1.12 Mn |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | 223.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 223.00 |
| Sep 30, 2025 | 315,087.00 |
| Dec 31, 2024 | 17,035.00 |